nsv6103221
- Organism: Homo sapiens
- Study:nstd212 (Wu et al. 2021)
- Variant Type:inversion
- Method Type:Sequencing
- Submitted on:GRCh38
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:1,209,972
- Publication(s):Wu et al. 2021
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 3188 SVs from 108 studies. See in: genome view
Overlapping variant regions from other studies: 3188 SVs from 108 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
nsv6103221 | Submitted genomic | GRCh38 (hg38) | Primary Assembly | NC_000002.12 | Chr2 | 95,946,252 | 97,156,223 | ||
nsv6103221 | Remapped | Good | GRCh37.p13 | Primary Assembly | First Pass | NC_000002.11 | Chr2 | 96,612,000 | 97,821,960 |
Variant Call Information
Variant Call ID | Type | Method | Analysis |
---|---|---|---|
nssv17519204 | inversion | Sequencing | Sequence alignment |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop |
---|---|---|---|---|---|---|---|---|---|
nssv17519204 | Submitted genomic | NC_000002.12:g.959 46252_97156223inv | GRCh38 (hg38) | NC_000002.12 | Chr2 | 95,946,252 | 97,156,223 | ||
nssv17519204 | Remapped | Good | NC_000002.11:g.966 12000_97821960inv | GRCh37.p13 | First Pass | NC_000002.11 | Chr2 | 96,612,000 | 97,821,960 |